PROCEPT BioRobotics investors face lead-plaintiff deadline in securities suit
A law firm says investors who lost money in PROCEPT BioRobotics stock may seek to lead a proposed securities fraud class action tied to alleged misleading statements about the company’s business and finances.
A law firm says investors who lost money in PROCEPT BioRobotics stock may seek to lead a proposed securities fraud class action tied to alleged misleading statements about the company’s business and finances.
Glancy Prongay Wolke & Rotter LLP said in a press release dated Aug. 18, 2026, that investors with losses in PROCEPT BioRobotics Corporation securities may apply to lead a proposed securities fraud class action. The release names PROCEPT BioRobotics, ticker PRCT, and sets a lead-plaintiff deadline of Sept. 22, 2026.
The firm said the lawsuit concerns statements it describes as materially false or misleading about the company’s business, operations and financial condition during a class period from Feb. 28, 2024, through Feb. 25, 2026. The allegations have not been proven in court, and no class has been certified.
The release says the complaint alleges PROCEPT used an extensive discount program to push bulk handpiece orders above procedure demand. It says that program allegedly pulled sales forward from future periods and inflated reported U.S. handpiece unit sales and revenues.
According to the release, the complaint also alleges customer orders exceeded underlying procedure demand throughout the class period, with the gap widening over time. It says excess field inventory and customer overstock reached more than 10,000 excess units by the end of the class period, and that the company overstated handpiece unit sales and the utilization of its field systems.
The law firm said those alleged conditions exposed PROCEPT to undisclosed operational and financial harm. The release also says investors may choose their own counsel and may remain absent class members if they take no action.
Glancy Prongay Wolke & Rotter LLP said it is based in Los Angeles and included contact information in the release. The firm also said the press release may be considered attorney advertising in some jurisdictions.
The next development is the Sept. 22, 2026, deadline for investors who want to seek lead-plaintiff status in the proposed case.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.